@article{b40298d487014c788ee9eaeea71e0313,
title = "SARS-CoV-2 and the rheumatology patient: The last 12 months and a boost in the future",
keywords = "COVID-19, autoimmune diseases, vaccination",
author = "Winthrop, {Kevin L.} and Whitley, {Richard J.} and Daniel Aletaha",
note = "Funding Information: Competing interests KLW has received research grants from Pfizer and consultant honorarium from Lilly, Regeneron, Gilead, Pfizer and Astra Zeneca. RW receives grant support from the NIH and serves as the Chair of NIAID{\textquoteright}s DSMBs for Coronavirus Vaccine Studies and for HIV. He is on the Board of Directors of Viros. DA received research grants from Abbvie, Amgen, Lilly, Novartis, Roche, SoBi and Sanofi, and consultant/ speaker honorarium from Abbvie, Amgen, Lilly, Merck, Novartis, Pfizer, Roche and Sandoz.",
year = "2021",
month = oct,
day = "1",
doi = "10.1136/annrheumdis-2021-221251",
language = "English (US)",
volume = "80",
pages = "1249--1251",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "10",
}